Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Regenerative Bio | 2022 | Angel | $10.0M | Cambridge |
| Tanma SCRM | 2022 | Series B | $10.0M | Haidian |
| Rongke Hydrogen | 2021 | Series B | $15.7M | Nanjing |
| GOSO | 2021 | Series Unknown | Undisclosed | Guangzhou |
| EKuaibao | 2021 | Series D | $154.0M | Beijing |
| Tendfo | 2021 | Series A | $15.4M | Shanghai |
| Hala | 2021 | Seed | $3.1M | Shanghai |
| Shuangqi Beverage Technology | 2021 | Seed | $1.6M | Beijing |
| Funiutang | 2021 | Series C | Undisclosed | Haidian |
| YIAUTO | 2021 | Series C | $70.0M | Xiamen |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Regenerative Bio | Angel | $10.0M | Cambridge, United States |
| 52 | Tanma SCRM | Series B | $10.0M | Haidian, China |
| 53 | Rongke Hydrogen | Series B | $15.7M | Nanjing, China |
| 54 | GOSO | Series Unknown | Undisclosed | Guangzhou, China |
| 55 | EKuaibao | Series D | $154.0M | Beijing, China |
| 56 | Tendfo | Series A | $15.4M | Shanghai, China |
| 57 | Hala | Seed | $3.1M | Shanghai, China |
| 58 | Shuangqi Beverage Technology | Seed | $1.6M | Beijing, China |
| 59 | Funiutang | Series C | Undisclosed | Haidian, China |
| 60 | YIAUTO | Series C | $70.0M | Xiamen, China |
Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.
Tanma SCRM is a full-process private domain traffic solution provider that helps customers improve their private domain traffic operations.
Rongke Hydrogen is a hydrogen fuel cell R&D company, mainly engaged in hydrogen fuel cell research, manufacturing, and sales.
GOSO specializes in lingerie and body care products.
EKuaibao is an agile enterprise expense reimbursement and management platform.
Tendfo develops a medical device for pulmonary embolism interventional therapy.
Hala is a nutrition brand.
Shuangqi Beverage Technology is a beverage production company engaged in manufacturing ready-to-drink beverage products.
Funiutang is an O2O brand that specializes in Hunan beef noodles and instant beef powder.
Yiauto is an automobile service platform.
Hok Bee provides to create new retail home furnishing pavilion.
Exegenesis Bio is a Gene therapy start-up.
Yunding Technology develops smart home security products and services.
Waimai Qingbao is a catering franchise information platform.
JHNYH.com is an e-commerce platform that provides petroleum products.
Quanwu Youpin is the furniture e-commerce platform.
Marriage Law is a legal consulting service platform.
Haitun Dingnai is a mobile-based application platform that allows its users to order domestic milk.
YuanYou provides intelligent manufacturing supply chain solutions for ceramics, refractory materials and other industries.
Lubo Education is an education service platform.
Dingdong Class is an online English learning platform for kids aged 5 to 10.
VIPFIT is an online personal fitness trainer platform.
Nihaozhiwu is a producer of honey products.
Qichacha delivers data and analytics on China-based private and public companies to consumers and enterprises via mobile app, web, and APIs.
PetPlus is a cute pet community WeChat applet.
K2VC has invested in 161 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
K2VC's top investment sectors include Manufacturing, Health Care, Food and Beverage, E-Commerce, Food Processing. The firm invests across 60 different industry categories.
Among tracked funding rounds, EKuaibao received $154.0M in a Series D round. K2VC's total known invested capital is $1.9B.
K2VC's average investment size is $17.7M across its portfolio of 161 companies.
Recent K2VC portfolio additions include Regenerative Bio, Tanma SCRM, Rongke Hydrogen, GOSO, EKuaibao. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors